C-MER Eye Care Holdings Limited (3309.HK)
- Previous Close
2.990 - Open
2.980 - Bid 2.970 x --
- Ask 3.020 x --
- Day's Range
2.980 - 3.020 - 52 Week Range
2.390 - 4.200 - Volume
12,000 - Avg. Volume
932,637 - Market Cap (intraday)
3.792B - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
60.40 - EPS (TTM)
0.050 - Earnings Date Mar 26, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date May 31, 2021
- 1y Target Est
--
C-MER Eye Care Holdings Limited, an investment holding company, provides ophthalmic services under the C-MER Dennis Lam brand name in Hong Kong and Mainland China. The company operates through four segments: HK Medical Business, Sales of Medical Consumables, Mainland China Ophthalmic Business, and Mainland China Dental Business. It provides dental, oncology, medical aesthetics, and laboratory services; and engages in the sale of vision aid products, such as glasses and lens, and medical consumables. The company also operates eye and surgery centers, and satellite clinics that provide cataract, glaucoma, strabismus and refractive surgeries, external eye diseases, and vitreoretinal disease services. In addition, it provides dental and other medical services. The company was founded in 2012 and is headquartered in Central, Hong Kong. C-MER Eye Care Holdings Limited is a subsidiary of C-MER Group Limited.
www.cmereye.com3,273
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: 3309.HK
Trailing total returns as of 5/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3309.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3309.HK
Valuation Measures
Market Cap
3.75B
Enterprise Value
3.56B
Trailing P/E
60.53
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.95
Price/Book (mrq)
2.03
Enterprise Value/Revenue
1.85
Enterprise Value/EBITDA
9.80
Financial Highlights
Profitability and Income Statement
Profit Margin
3.22%
Return on Assets (ttm)
2.75%
Return on Equity (ttm)
4.33%
Revenue (ttm)
1.92B
Net Income Avi to Common (ttm)
62M
Diluted EPS (ttm)
0.050
Balance Sheet and Cash Flow
Total Cash (mrq)
557.42M
Total Debt/Equity (mrq)
18.21%
Levered Free Cash Flow (ttm)
64.56M
Company Insights: 3309.HK
3309.HK does not have Company Insights